Botulinum neurotoxin a changes conformation upon binding to ganglioside GT1b

被引:51
|
作者
Yowler, BC [1 ]
Schengrund, CL [1 ]
机构
[1] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA
关键词
D O I
10.1021/bi0494673
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, the kinetics of the binding of botulinum neurotoxin A (BoNT/A) to ganglioside GT1b were studied using surface plasmon resonance (SPR). The neurotoxin bound polysialylated gangliosides, and that binding was affected by the ionic strength of the buffer. Although the level of binding was decreased at higher ionic strengths, it could be easily observed in Tris buffer, containing 150 mM NaCl. Data analysis revealed that the binding of BoNT/A to a GT1b-containing phospholipid monolayer did not fit a traditional 1: 1 model. Subsequent studies, in which the time of contact between BoNT/A and GT1b was varied, indicated that the BoNT/A-GT1b complex became more stable over time, as evidenced by its reduced rate of dissociation. Circular dichroism indicated that when BoNT/A was incubated with GT1b, it underwent a conformational change that resulted in an increase in alpha-helix content and a decrease in beta-sheet content. Therefore, the SPR kinetic data were fit to a conformational change model and kinetic rate constants determined. The apparent K-D values obtained for the binding of BoNT/A to ganglioside GT1b ranged from 2.83 x 10(-7) to 1.86 x 10(-7) M, depending on the ionic strength of the buffer.
引用
收藏
页码:9725 / 9731
页数:7
相关论文
共 50 条
  • [1] BINDING OF BOTULINUM AND TETANUS NEUROTOXINS TO GANGLIOSIDE GT1B AND DERIVATIVES THEREOF
    SCHENGRUND, CL
    DASGUPTA, BR
    RINGLER, NJ
    JOURNAL OF NEUROCHEMISTRY, 1991, 57 (03) : 1024 - 1032
  • [2] Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex
    Kohda, Tomoko
    Ihara, Hideshi
    Seto, Yukiji
    Tsutsuki, Hiroyasu
    Mukamoto, Masafumi
    Kozaki, Shunji
    MICROBIAL PATHOGENESIS, 2007, 42 (2-3) : 72 - 79
  • [3] Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics
    Venkateshwari, Sureshkumar
    Veluraja, Kasinadar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 30 (03): : 255 - 268
  • [4] Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins
    Kozaki, S
    Kamata, Y
    Watarai, S
    Nishiki, T
    Mochida, S
    MICROBIAL PATHOGENESIS, 1998, 25 (02) : 91 - 99
  • [5] GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside
    Hamasaki, H
    Aoyagi, M
    Kasama, T
    Handa, S
    Hirakawa, K
    Taki, T
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1437 (01): : 93 - 99
  • [6] SYNAPTOTAGMIN ASSOCIATED WITH GANGLIOSIDES GT1B/GD1A IS A RECEPTOR FOR BOTULINUM TYPE-B NEUROTOXIN
    NISHIKI, T
    TOKUYAMA, Y
    NEMOTO, Y
    YSOHIDA, A
    KAMATA, Y
    TAKAHASHI, M
    KOZAKI, S
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S11 - S11
  • [7] Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics (vol 30, pg 255, 2012)
    Venkateshwari, Sureshkumar
    Veluraja, Kasinadar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 30 (04): : 503 - 503
  • [8] GANGLIOSIDE GT1B INHIBITS ATTACHMENT OF CULTURED KERATINOCYTES TO FIBRONECTIN
    PALLER, AS
    ARNSMEIER, SL
    CHEN, JD
    CLINICAL RESEARCH, 1993, 41 (02): : A435 - A435
  • [9] GANGLIOSIDE GT1B INHIBITS ATTACHMENT OF CULTURED KERATINOCYTES TO FIBRONECTIN
    PALLER, AS
    ARNSMEIER, SL
    CHEN, JD
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 550 - 550
  • [10] Liposomes Functionalized with GT1b Ganglioside with High Affinity for Amyloid β-peptide
    Salvati, Elisa
    Masserini, Massimo
    Sesana, Silvia
    Sonnino, Sandro
    Re, Francesca
    Gregori, Maria
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 : 33 - 36